https://charts.traderzeitung.de/phases/CH0334081137
string(1491) "{"isin":"CH0334081137","name":"CRISPR Therapeutics AG","stock_id_xnas":7872883,"stock_id_xnys":null,"generated_at":"2026-08-13 17:50:00","days":[{"date":"2026-08-11","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":53.8,"close_at":"2026-08-11 15:25:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":54.035,"close_at":"2026-08-11 21:59:00","complete":true,"perf_pct":0.4368},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":53.92,"close_at":"2026-08-11 22:32:00","complete":true,"perf_pct":-0.2128}]},{"date":"2026-08-12","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":54.37,"close_at":"2026-08-12 14:56:00","complete":true,"perf_pct":0.8346},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":54,"close_at":"2026-08-12 21:59:00","complete":true,"perf_pct":-0.6805},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":54,"close_at":"2026-08-12 22:35:00","complete":true,"perf_pct":0}]},{"date":"2026-08-13","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":54.04,"close_at":"2026-08-13 14:49:00","complete":true,"perf_pct":0.0741},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":53.69,"close_at":"2026-08-13 17:49:00","complete":false,"perf_pct":-0.6477},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
CRISPR Therapeutics Aktie News & Nachrichten
Trading-Room

CRISPR Therapeutics Aktie News & Nachrichten

[WKN: A2AT0Z | Symbol: CRSP]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel
Trader-Zeitung Agents
Agentische Berichterstattung zu CRISPR Therapeutics
Kursziele und Analysen
Analystenmeinungen zu CRISPR Therapeutics

Artikel aus der Redaktion der Trader-Zeitung

CRISPR Therapeutics

Cathie Wood warnt vor Rezession – setzt aber auf KI, Tesla und Biotech als Gewinner

Während die USA laut ARK-Invest-Chefin Cathie Wood auf eine wirtschaftliche Abkühlung zusteuern, sieht...

  • ‹
  • 1
  • ›
CRISPR Therapeutics Nachrichtenticker öffnen
MT Newswires 04.08.2026 17:50 Uhr

Crispr Therapeutics verzeichnet ein „ruhiges“ Quartal, da Casgevy voranschreitet und SiRNA-Daten bevorstehen, so RBC

11:49 AM EDT, 04.08.2026 (MT Newswires) -- Crispr Therapeutics (CRSP) meldete ein relativ ruhiges Q2, wobei Casgevy weiterhin kommerzielle Zugkraft ge

MT Newswires 03.08.2026 22:25 Uhr

-- Earnings Flash (CRSP): CRISPR Therapeutics AG meldet Q2-Umsatz von 10,2 Mio. $, verglichen mit FactSet-Schätzung von 7,4 Mio. $

04:17 PM EDT, 03.08.2026 (MT Newswires) -- http://www.mtnewswires.com Copyright © 2026 MT Newswires. All rights reserved. MT Newswires does not provid